<DOC>
	<DOCNO>NCT02005666</DOCNO>
	<brief_summary>This Randomized , Double-blind , Multicentric , Parallel-group , Active Placebo Controlled , Three Arm Clinical Study . The main objective evaluate bioequivalence Test formulation ( Clindamycin Phosphate 1.2 % /Benzoyl peroxide 5 % gel ) Cadila Healthcare Reference formulation ( DUAC® Gel Stiefel Laboratories ) ratio 2:2:1 Test drug , Reference drug Placebo respectively . Total study duration period 78 day include treatment duration 77 day . 850 subject enrol ( randomize ) per inclusion exclusion criterion mention protocol .</brief_summary>
	<brief_title>To Compare Efficacy Safety Clindamycin Phosphate 1.2 % / Benzoyl Peroxide 5 % Gel CHL Versus DUAC® Gel</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>1 . Healthy male non pregnant female age ≥ 12 ≤ 40 year clinical diagnosis Acne vulgaris 2 . On face , ≥ 25 noninflammatory lesion ( i.e. , open close comedo ) AND ≥ 20 inflammatory lesion ( i.e. , papule pustule ) AND ≤ 2 nodulocystic lesion ( i.e. , nodule cyst ) . 3 . Investigator 's Global Assessment ( IGA ) acne severity grade 2 , 3 OR 4 4 . Willing refrain use topical acne medication antibiotic 11 week treatment period . 5 . If female childbearing potential , willing use acceptable form birth control study . 6 . Have use brand makeup minimum period 2 week prior randomization , subject use makeup , agree change makeup brand type study . 7 . Willing provide write informed consent assent ( HIPAA consent/authorization , applicable ) 1 . Presence skin condition would interfere diagnosis assessment acne vulgaris ( e.g. , face : rosacea , dermatitis , psoriasis , squamous cell carcinoma , eczema , acneform eruption cause medication , steroid acne , steroid folliculitis , bacterial folliculitis ) . 2 . Patients acne conglobata , acne fulminans secondary acne ( e.g . : chloracne drug induce acne ) . 3 . Excessive facial hair ( e.g . beard , sideburn , moustache , etc . ) would interfere diagnosis assessment acne vulgaris . Well trim moustache allow . 4 . History hypersensitivity allergy benzoyl peroxide clindamycin and/or study medication ingredient . 5 . Patients severe intense irritation Face . 6 . Use within 6 month prior baseline ( Randomization ) oral retinoids ( e.g . Accutane® ) therapeutic vitamin A supplement great 10,000 units/day ( multivitamin allow ) . 7 . Use le 3 month prior baseline ( Randomization ) estrogens oral contraceptive ; use therapy allow remain constant throughout study . 8 . Use face within 1 month prior baseline ( Randomization ) study : 1 ) cryodestruction chemodestruction , 2 ) dermabrasion , 3 ) photodynamic therapy , 4 ) acne surgery , 5 ) intralesional steroid , 6 ) xray therapy . 9 . Use within 1 month prior baseline ( Randomization ) : 1 ) spironolactone , 2 ) systemic steroid , 3 ) systemic antibiotic , 4 ) systemic treatment acne vulgaris ( oral retinoids , require 6month washout ) , 5 ) systemic antiinflammatory agent . 10 . Use within 2 week prior baseline ( Randomization ) : 1 ) topical steroid , 2 ) topical retinoids , 3 ) topical acne treatment include overthecounter preparation , 4 ) topical antiinflammatory agent , 5 ) medicate cleanser 6 ) topical antibiotic . 11 . Patients general anesthesia reason patient receive neuromuscular block agent within 14 day prior study entry ( Randomization ) . 12 . Concomitant use facial product contain glycolic acid , mask , wash soap contain benzoyl peroxide salicylic acid , non mild cleanser moisturizers contain retinol , salicylic α βhydroxy acid . 13 . Concomitant use megadoses certain vitamin ( vitamin D vitamin B12 ) , haloperidol , halogens iodide bromide , lithium , hydantoin phenobarbital . 14 . Facial procedure ( chemical laser peel , microdermabrasion , etc . ) within past 2 week study . 15 . Concomitant use tan booth sunbathe . 16 . A significant medical history currently immunocompromised 17 . Have systemic dermatologic disease may affect evaluation study result . 18 . Have history regional enteritis , ulcerative colitis , pseudomembranous colitis antibioticassociated colitis . 19 . Subjects clinically significant unstable medical disorder , lifethreatening disease , current malignancy . 20 . Subjects engage activity involve excessive prolonged exposure sunlight . 21 . Subjects History Alcohol abuse drug abuse within 2 year prior Randomization . 22 . Female subject breastfeed plan become pregnant . 23 . Subjects treat investigational drug investigational device within period 30 day prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>DUAC</keyword>
	<keyword>CADILA</keyword>
	<keyword>CLIANTHA</keyword>
</DOC>